Displaying drugs 9701 - 9725 of 14772 in total
NCX 701
Nitroparacetamol (NCX-701) is a newly synthesized nitric oxide-releasing derivative of paracetamol.
Investigational
Cefalonium
Experimental
Vet approved
Barasertib
Barasertib has been used in trials studying the treatment of Tumors, Lymphoma, Solid Tumors, Solid Tumours, and Myeloid Leukemia, among others.
Investigational
Matched Description: … Barasertib has been used in trials studying the treatment of Tumors, Lymphoma, Solid Tumors, Solid Tumours, and …
Golvatinib
Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
Investigational
Matched Description: … Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and …
Cefetamet
Experimental
Halofuginone
Halofuginone is a low molecular weight quinazolinone alkaloid, and a potent inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 (MMP-2) gene expression. Halofuginone also effectively suppresses tumor progression and metastasis in mice. Collgard Biopharmaceuticals is developing halofuginone for the treatment of scleroderma and received orphan drug designation from the U.S....
Investigational
Vet approved
Matched Description: … Food and Drug Administration in March, 2000. ... (I) and matrix metalloproteinase 2 (MMP-2) gene expression. ... Halofuginone also effectively suppresses tumor progression and metastasis in mice. …
Hymenialdisine
Experimental
PF-00356231
Experimental
MK-0557
MK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia.
Investigational
Matched Description: … MK0557 has been investigated for the treatment of Schizophrenia and Paranoid Schizophrenia. …
Displaying drugs 9701 - 9725 of 14772 in total